Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

被引：291
作者：
Akter, Kawser [1 ]
Lanza, Emily A. [1 ]
Martin, Stephen A. [1 ]
Myronyuk, Natalie [1 ]
Rua, Melanie [1 ]
Raffa, Robert B. [1 ]
机构：
[1] Temple Univ, Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19140 USA
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 71卷 / 03期
关键词：
Alzheimer's disease; clinical trial; diabetes; insulin physiology; BLOOD-BRAIN-BARRIER; END-PRODUCTS AGES; GROWTH-FACTOR-I; MILD COGNITIVE IMPAIRMENT; ISLET AMYLOID POLYPEPTIDE; INSULIN-DEGRADING ENZYME; ACTIVATED RECEPTOR-GAMMA; CENTRAL-NERVOUS-SYSTEM; PROTEIN-TAU TAU; OXIDATIVE STRESS;
D O I：
10.1111/j.1365-2125.2010.03830.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Epidemiological and basic science evidence suggest a possible shared pathophysiology between type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD). It has even been hypothesized that AD might be 'type 3 diabetes'. The present review summarizes some of the evidence for the possible link, putative biochemical pathways and ongoing clinical trials of antidiabetic drugs in AD patients. The primary and review literature were searched for articles published in peer-reviewed sources that were related to a putative connection between T2DM and AD. In addition, public sources of clinical trials were searched for the relevant information regarding the testing of antidiabetic drugs in AD patients. The evidence for a connection between T2DM and AD is based upon a variety of diverse studies, but definitive biochemical mechanisms remain unknown. Additional study is needed to prove the existence or the extent of a link between T2DM and AD, but sufficient evidence exists to warrant further study. Presently, AD patients might benefit from treatment with pharmacotherapy currently used to treat T2DM and clinical trials of such therapy are currently underway.
引用
收藏
页码：365 / 376
页数：12
相关论文
共 161 条
[71]   Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes [J].
Kaneto, Hideaki ;
Matsuoka, Taka-Aki ;
Katakami, Naoto ;
Kawamori, Dan ;
Miyatsuka, Takeshi ;
Yoshiuchi, Kazutomi ;
Yasuda, Tetsuyuki ;
Sakamoto, Ken'ya ;
Yamasaki, Yoshimitsu ;
Matsuhisa, Munehide .
CURRENT MOLECULAR MEDICINE, 2007, 7 (07) :674-686
[72]   Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice [J].
Killick, Richard ;
Scales, Georgie ;
Leroy, Karelle ;
Causevic, Mirsada ;
Hooper, Claudie ;
Irvine, Elaine E. ;
Choudhury, Agharul I. ;
Drinkwater, Laura ;
Kerr, Fiona ;
Al-Qassab, Hind ;
Stephenson, John ;
Yilmaz, Zehra ;
Giese, K. Peter ;
Brion, Jean-Pierre ;
Withers, Dominic J. ;
Lovestone, Simon .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 386 (01) :257-262
[73]   Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains [J].
Kitamura, Y ;
Shimohama, S ;
Koike, H ;
Kakimura, J ;
Matsuoka, Y ;
Nomura, Y ;
Gebicke-Haerter, PJ ;
Taniguchi, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 254 (03) :582-586
[74]   Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease [J].
Kivipelto, M ;
Ngandu, T ;
Fratiglioni, L ;
Viitanen, M ;
Kåreholt, I ;
Winblad, B ;
Helkala, EL ;
Tuomilehto, J ;
Soininen, H ;
Nissinen, A .
ARCHIVES OF NEUROLOGY, 2005, 62 (10) :1556-1560
[75]   MICROTUBULE-ASSOCIATED PROTEIN TAU (TAU) IS A MAJOR ANTIGENIC COMPONENT OF PAIRED HELICAL FILAMENTS IN ALZHEIMER-DISEASE [J].
KOSIK, KS ;
JOACHIM, CL ;
SELKOE, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) :4044-4048
[76]  
Kroner Z, 2009, ALTERN MED REV, V14, P373
[77]   Migraine as a risk factor for subclinical brain lesions [J].
Kruit, MC ;
van Buchem, MA ;
Hofman, PAM ;
Bakkers, JTN ;
Terwindt, GM ;
Ferrari, MD ;
Launer, LJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (04) :427-434
[78]   Dementia and Alzheimer disease incidence - A prospective cohort study [J].
Kukull, WA ;
Higdon, R ;
Bowen, JD ;
McCormick, WC ;
Teri, L ;
Schellenberg, GD ;
van Belle, G ;
Jolley, L ;
Larson, EB .
ARCHIVES OF NEUROLOGY, 2002, 59 (11) :1737-1746
[79]   Epidemiology of Alzheimer's disease: Race effects, area variation, and clustering [J].
Laditka, JN ;
Cornman, CB ;
Lane, M ;
Porter, CN ;
Davis, DR .
NEUROBIOLOGY OF AGING, 2004, 25 :S392-S393
[80]   APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome [J].
Lai, F ;
Kammann, E ;
Rebeck, GW ;
Anderson, A ;
Chen, Y ;
Nixon, RA .
NEUROLOGY, 1999, 53 (02) :331-336
3456789101112